- Torglip M 50/1000 mg Tablet offers comprehensive glucose control by targeting both the liver's glucose production and the pancreas's insulin response.
- This medication lowers the risk of hypoglycemia compared to some other classes of diabetes medications like sulfonylureas.
- Torglip M 50/1000 mg Tablet has a weight-neutral profile, meaning it generally does not cause the weight gain associated with some other anti-diabetic drugs.
- The convenience of taking Torglip M 50/1000 mg Tablet as a single tablet improves adherence to the prescribed treatment plan.
- Reduction in HbA1c levels is achieved with Torglip M 50/1000 mg Tablet, helping to lower the long-term risk of diabetic complications like nerve, eye, or kidney damage.
- Torglip M 50/1000 mg Tablet is effective in managing blood sugar levels when diet and exercise alone are insufficient.
- This therapy can be used in conjunction with other diabetes medications under medical supervision.
- Torglip M 50/1000 mg Tablet supports better post-meal glucose regulation, making it suitable for individuals with fluctuating blood sugar levels.
Torglip M 50/1000 mg Tablet - Strip of 10
Compositions : Metformin Hydrochloride 1000mg + Vildagliptin 50mg
MRP :
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Torrent Pharmaceuticals Ltd
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Torglip M 50/1000 mg Tablet is a fixed-dose oral anti-diabetic combination that plays a crucial role in managing type 2 diabetes mellitus in adults. This formulation combines two active ingredients: Metformin hydrochloride and Vildagliptin. Metformin, a biguanide, works primarily by reducing hepatic glucose production, improving insulin sensitivity, and enhancing peripheral glucose uptake. On the other hand, Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that prolongs incretin activity, which increases insulin secretion and decreases glucagon release in a glucose-dependent manner. Together, these mechanisms of action make Torglip M 50/1000 mg Tablet an effective option for patients who do not achieve adequate glycemic control with Metformin alone or when combination therapy is clinically appropriate. The primary purpose of Torglip M 50/1000 mg Tablet is to improve overall glycemic control by targeting both fasting plasma glucose and postprandial glucose levels. This combination therapy is particularly beneficial for individuals who require additional support in managing their blood sugar levels. Torglip M 50/1000 mg Tablet is typically prescribed alongside dietary management and regular physical activity as part of a comprehensive diabetes care plan. The convenience of taking Torglip M 50/1000 mg Tablet as a single tablet enhances patient adherence to their treatment regimen, making it easier for individuals to manage their diabetes effectively. With its dual-action approach, Torglip M 50/1000 mg Tablet not only helps in controlling blood sugar levels but also reduces the risk of long-term complications associated with diabetes, such as nerve damage, kidney issues, and eye problems. Overall, Torglip M 50/1000 mg Tablet represents a significant advancement in diabetes management, providing patients with a reliable option to achieve better glycemic control and improve their quality of life.
Product Details
Torglip M 50/1000 mg Tablet combines two antidiabetic medicines: Metformin and Vildagliptin. Metformin lowers glucose production in the liver and increases insulin sensitivity, while Vildagliptin enhances insulin release from the pancreas and decreases hormones that raise blood sugar levels. Together, they provide better control of blood sugar.
- Metformin reduces hepatic glucose production and improves insulin sensitivity.
- Vildagliptin inhibits DPP-4 enzyme activity, prolonging incretin hormone effects.
- This combination leads to increased insulin secretion in response to meals.
- Torglip M 50/1000 mg Tablet helps decrease glucagon release, which lowers blood sugar levels.
- Both components work synergistically to improve overall glycemic control.
- By targeting different mechanisms, Torglip M 50/1000 mg Tablet effectively manages fasting and postprandial glucose levels.
- The formulation aids in reducing HbA1c levels over time.
- Torglip M 50/1000 mg Tablet should be taken orally with water; swallow the tablet whole without crushing or chewing.
- It is recommended to take Torglip M 50/1000 mg Tablet with meals to minimize stomach upset.
- Follow your doctor's instructions regarding dosage; your doctor will adjust it based on your blood sugar response and tolerability.
- Maintain lifestyle measures such as a balanced diet and regular exercise while using Torglip M 50/1000 mg Tablet.
- Do not self-adjust the dosage; consult your doctor before making any changes to your treatment plan.
- Regular monitoring of blood sugar levels is advised while on Torglip M 50/1000 mg Tablet.
- Consult your healthcare provider for any concerns regarding the duration of treatment with Torglip M 50/1000 mg Tablet.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables while using Torglip M 50/1000 mg Tablet.
- Engage in regular physical activity to enhance the effectiveness of Torglip M 50/1000 mg Tablet in managing blood sugar levels.
- Always carry a source of fast-acting sugar for emergencies related to low blood sugar while on Torglip M 50/1000 mg Tablet.
- Stay well-hydrated, especially during illnesses that may cause vomiting or diarrhea while taking Torglip M 50/1000 mg Tablet.
- Regularly monitor your blood sugar levels as advised by your healthcare provider while using Torglip M 50/1000 mg Tablet.
Safety Advice
Side Effects
- Common side effects of Torglip M 50/1000 mg Tablet may include nausea or vomiting.
- Diarrhea or abdominal pain can occur as your body adjusts to Torglip M 50/1000 mg Tablet.
- Loss of appetite and a metallic taste in the mouth are also reported side effects.
- Headaches or dizziness may be experienced by some users of Torglip M 50/1000 mg Tablet.
- Serious side effects that may require immediate medical attention include lactic acidosis, characterized by severe exhaustion or muscle pain.
- Symptoms of pancreatitis such as severe stomach pain radiating to the back should be evaluated promptly.
- Liver dysfunction symptoms like yellowing of the skin or eyes may indicate a serious reaction to Torglip M 50/1000 mg Tablet.
Precautions and Warnings
- Torglip M 50/1000 mg Tablet is not recommended for individuals with severe kidney or liver impairment.
- Consult your doctor before using Torglip M 50/1000 mg Tablet if you are pregnant or breastfeeding.
- Avoid excessive alcohol consumption while taking Torglip M 50/1000 mg Tablet due to increased risk of lactic acidosis.
- Monitor kidney function regularly while on Torglip M 50/1000 mg Tablet, especially if you have existing kidney issues.
- Driving may be affected if blood sugar levels fluctuate; use caution when operating vehicles.
- Inform your healthcare provider about all medications you are taking to avoid potential drug interactions with Torglip M 50/1000 mg Tablet.
FAQs
Torglip M 50/1000mg Tablet is prescribed to enhance blood sugar control in adults with type 2 diabetes. It helps improve the body's response to insulin and regulates glucose levels after meals.
2. How should I take Torglip M 50/1000mg Tablet?
Take Torglip M 50/1000mg Tablet exactly as directed by your doctor. It is usually taken with or after meals to reduce stomach upset. Swallow the tablet whole with water.
3. Does Torglip M 50/1000mg Tablet cause weight gain?
Torglip M 50/1000mg Tablet is generally considered weight-neutral and does not typically lead to weight gain when used as directed.
4. How long does it take to see results from Torglip M 50/1000mg Tablet?
Blood sugar levels may start improving within a few days of taking Torglip M 50/1000mg Tablet, but full benefits are usually observed over several weeks.
5. What should I do if I feel unusually weak or unwell?
If you feel unusually weak or unwell while taking Torglip M 50/1000mg Tablet, contact your doctor immediately as these could be signs of rare side effects.
6. Can I drink alcohol while taking Torglip M 50/1000mg Tablet?
It is advisable to limit alcohol intake while using Torglip M 50/1000mg Tablet as excessive alcohol can increase the risk of side effects.
7. How should I store Torglip M 50/1000mg Tablet?
Store Torglip M 50/1000mg Tablet at room temperature in a dry place away from direct sunlight and moisture. Keep it out of reach of children.
Instructions
Directions for Use
Storage and Disposal
- Store at room temperature (below 30°C), away from direct sunlight and moisture[3].
- Keep out of reach of children.
- Dispose of unused medicine responsibly, as per pharmacist guidance.
More Information
| SKU | 431060 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Torrent Pharmaceuticals Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage |
|
| Seller | Kogland Commerce Pvt Ltd (TN) |
Torglip M 50/1000 mg Tablet is a fixed-dose oral anti-diabetic combination that plays a crucial role in managing type 2 diabetes mellitus in adults. This formulation combines two active ingredients: Metformin hydrochloride and Vildagliptin. Metformin, a biguanide, works primarily by reducing hepatic glucose production, improving insulin sensitivity, and enhancing peripheral glucose uptake. On the other hand, Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that prolongs incretin activity, which increases insulin secretion and decreases glucagon release in a glucose-dependent manner. Together, these mechanisms of action make Torglip M 50/1000 mg Tablet an effective option for patients who do not achieve adequate glycemic control with Metformin alone or when combination therapy is clinically appropriate. The primary purpose of Torglip M 50/1000 mg Tablet is to improve overall glycemic control by targeting both fasting plasma glucose and postprandial glucose levels. This combination therapy is particularly beneficial for individuals who require additional support in managing their blood sugar levels. Torglip M 50/1000 mg Tablet is typically prescribed alongside dietary management and regular physical activity as part of a comprehensive diabetes care plan. The convenience of taking Torglip M 50/1000 mg Tablet as a single tablet enhances patient adherence to their treatment regimen, making it easier for individuals to manage their diabetes effectively. With its dual-action approach, Torglip M 50/1000 mg Tablet not only helps in controlling blood sugar levels but also reduces the risk of long-term complications associated with diabetes, such as nerve damage, kidney issues, and eye problems. Overall, Torglip M 50/1000 mg Tablet represents a significant advancement in diabetes management, providing patients with a reliable option to achieve better glycemic control and improve their quality of life.
- Torglip M 50/1000 mg Tablet offers comprehensive glucose control by targeting both the liver's glucose production and the pancreas's insulin response.
- This medication lowers the risk of hypoglycemia compared to some other classes of diabetes medications like sulfonylureas.
- Torglip M 50/1000 mg Tablet has a weight-neutral profile, meaning it generally does not cause the weight gain associated with some other anti-diabetic drugs.
- The convenience of taking Torglip M 50/1000 mg Tablet as a single tablet improves adherence to the prescribed treatment plan.
- Reduction in HbA1c levels is achieved with Torglip M 50/1000 mg Tablet, helping to lower the long-term risk of diabetic complications like nerve, eye, or kidney damage.
- Torglip M 50/1000 mg Tablet is effective in managing blood sugar levels when diet and exercise alone are insufficient.
- This therapy can be used in conjunction with other diabetes medications under medical supervision.
- Torglip M 50/1000 mg Tablet supports better post-meal glucose regulation, making it suitable for individuals with fluctuating blood sugar levels.
Torglip M 50/1000 mg Tablet combines two antidiabetic medicines: Metformin and Vildagliptin. Metformin lowers glucose production in the liver and increases insulin sensitivity, while Vildagliptin enhances insulin release from the pancreas and decreases hormones that raise blood sugar levels. Together, they provide better control of blood sugar.
- Metformin reduces hepatic glucose production and improves insulin sensitivity.
- Vildagliptin inhibits DPP-4 enzyme activity, prolonging incretin hormone effects.
- This combination leads to increased insulin secretion in response to meals.
- Torglip M 50/1000 mg Tablet helps decrease glucagon release, which lowers blood sugar levels.
- Both components work synergistically to improve overall glycemic control.
- By targeting different mechanisms, Torglip M 50/1000 mg Tablet effectively manages fasting and postprandial glucose levels.
- The formulation aids in reducing HbA1c levels over time.
- Torglip M 50/1000 mg Tablet should be taken orally with water; swallow the tablet whole without crushing or chewing.
- It is recommended to take Torglip M 50/1000 mg Tablet with meals to minimize stomach upset.
- Follow your doctor's instructions regarding dosage; your doctor will adjust it based on your blood sugar response and tolerability.
- Maintain lifestyle measures such as a balanced diet and regular exercise while using Torglip M 50/1000 mg Tablet.
- Do not self-adjust the dosage; consult your doctor before making any changes to your treatment plan.
- Regular monitoring of blood sugar levels is advised while on Torglip M 50/1000 mg Tablet.
- Consult your healthcare provider for any concerns regarding the duration of treatment with Torglip M 50/1000 mg Tablet.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables while using Torglip M 50/1000 mg Tablet.
- Engage in regular physical activity to enhance the effectiveness of Torglip M 50/1000 mg Tablet in managing blood sugar levels.
- Always carry a source of fast-acting sugar for emergencies related to low blood sugar while on Torglip M 50/1000 mg Tablet.
- Stay well-hydrated, especially during illnesses that may cause vomiting or diarrhea while taking Torglip M 50/1000 mg Tablet.
- Regularly monitor your blood sugar levels as advised by your healthcare provider while using Torglip M 50/1000 mg Tablet.
Side Effects
- Common side effects of Torglip M 50/1000 mg Tablet may include nausea or vomiting.
- Diarrhea or abdominal pain can occur as your body adjusts to Torglip M 50/1000 mg Tablet.
- Loss of appetite and a metallic taste in the mouth are also reported side effects.
- Headaches or dizziness may be experienced by some users of Torglip M 50/1000 mg Tablet.
- Serious side effects that may require immediate medical attention include lactic acidosis, characterized by severe exhaustion or muscle pain.
- Symptoms of pancreatitis such as severe stomach pain radiating to the back should be evaluated promptly.
- Liver dysfunction symptoms like yellowing of the skin or eyes may indicate a serious reaction to Torglip M 50/1000 mg Tablet.
Precautions and Warnings
- Torglip M 50/1000 mg Tablet is not recommended for individuals with severe kidney or liver impairment.
- Consult your doctor before using Torglip M 50/1000 mg Tablet if you are pregnant or breastfeeding.
- Avoid excessive alcohol consumption while taking Torglip M 50/1000 mg Tablet due to increased risk of lactic acidosis.
- Monitor kidney function regularly while on Torglip M 50/1000 mg Tablet, especially if you have existing kidney issues.
- Driving may be affected if blood sugar levels fluctuate; use caution when operating vehicles.
- Inform your healthcare provider about all medications you are taking to avoid potential drug interactions with Torglip M 50/1000 mg Tablet.
Torglip M 50/1000mg Tablet is prescribed to enhance blood sugar control in adults with type 2 diabetes. It helps improve the body's response to insulin and regulates glucose levels after meals.
2. How should I take Torglip M 50/1000mg Tablet?
Take Torglip M 50/1000mg Tablet exactly as directed by your doctor. It is usually taken with or after meals to reduce stomach upset. Swallow the tablet whole with water.
3. Does Torglip M 50/1000mg Tablet cause weight gain?
Torglip M 50/1000mg Tablet is generally considered weight-neutral and does not typically lead to weight gain when used as directed.
4. How long does it take to see results from Torglip M 50/1000mg Tablet?
Blood sugar levels may start improving within a few days of taking Torglip M 50/1000mg Tablet, but full benefits are usually observed over several weeks.
5. What should I do if I feel unusually weak or unwell?
If you feel unusually weak or unwell while taking Torglip M 50/1000mg Tablet, contact your doctor immediately as these could be signs of rare side effects.
6. Can I drink alcohol while taking Torglip M 50/1000mg Tablet?
It is advisable to limit alcohol intake while using Torglip M 50/1000mg Tablet as excessive alcohol can increase the risk of side effects.
7. How should I store Torglip M 50/1000mg Tablet?
Store Torglip M 50/1000mg Tablet at room temperature in a dry place away from direct sunlight and moisture. Keep it out of reach of children.
Directions for Use
Storage and Disposal
- Store at room temperature (below 30°C), away from direct sunlight and moisture[3].
- Keep out of reach of children.
- Dispose of unused medicine responsibly, as per pharmacist guidance.
| SKU | 431060 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Torrent Pharmaceuticals Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage |
|
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account